James E Galvin

NIH Rank #98

Researcher identity and coverage

Current affiliation: Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity: Profile ID 2085729Search this ID in NIH RePORTER
ScienceDex PI coverage: FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

Linked Award Amount

$20.4M

Full award amounts, FY2025

Award Records

Records listing this PI

Award-Linked Rank

#98

By linked amount among FY2025 PIs

Earliest Year Loaded

2024

ScienceDex PI coverage

Linked NIH award amounts and rank by fiscal year.

NIH award records listing James E Galvin as a PI. Multi-PI records show the full award amount for context.

5R01AG080536-03R01
A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB)
Eip Pharma, Inc.
$6.1M
award amount
1R01AG092949-01R01
FDA approved IND 29644: Multicenter Phase 1 Trial to Evaluate Safety and Immunogenicity of Preventive Tau Vaccine, AV-1980R/A, in cognitively unimpaired preclinical AD participants.
Institute for Molecular Medicine
$5.3M
award amount
4RF1AG075904-02RF1
Alzheimer's Disease and Related Dementias (ADRD) prevalence in American Samoa
American Samoa Community Cancer Coalitio
$4.1M
award amount
5R01AG071514-05R01
Multicultural Community Dementia Screening
University of Miami School of Medicine
$2.5M
award amount
5U01AG084528-02U01
IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)
Institute for Molecular Medicine
$1.8M
award amount
5T32AG081170-02T32
Cross-disciplinary research opportunity for training in AD/ADRD science (CROSSROADS)
University of Miami School of Medicine
$558.7K
award amount